Company Filing History:
Years Active: 2012
Title: **Majel Cervantes Llanos: Innovator in Multiple Sclerosis Treatment**
Introduction
Majel Cervantes Llanos, a trailblazing inventor from Ciudad de la Habana, Cuba, has made significant contributions to the field of medical science. With a focus on innovative treatments for autoimmune diseases, her work showcases the intersection of biotechnology and healthcare.
Latest Patents
Majel holds a notable patent for her invention titled "Treatment of multiple sclerosis by administration of interferon alpha and C-phycocyanin." This groundbreaking invention combines Interferon alpha and C-Phycocyanin (IFN-α/C-Phyco) to create a pharmaceutical preparation aimed at treating autoimmune diseases, allergies, and cancer. The unique properties of this combination exhibit anti-inflammatory, immunomodulatory, antioxidant, anti-viral, anti-proliferative, and anti-tumoral effects. These characteristics, alongside the capacity to induce regulatory T cells, form the foundation of this innovative approach to treatment.
Career Highlights
Majel is affiliated with the Centro de Ingeniería Genética y Biotecnología, where she collaborates with an impressive team dedicated to advancing genetic engineering and biotechnological solutions. Her career reflects a commitment to exploring new therapeutic avenues that offer hope to individuals suffering from complex health conditions.
Collaborations
Throughout her career, Majel has worked alongside esteemed colleagues, including Giselle Penton Rol and Eduardo Penton Arias. Their collective efforts underscore the importance of teamwork and collaboration in driving innovation within the medical field.
Conclusion
Majel Cervantes Llanos stands out as an influential figure in biotechnology, with her innovations poised to impact the treatment of multiple sclerosis and other autoimmune diseases. Her dedication to research and inventive solutions exemplifies the potential of biotechnological advancements in improving patient outcomes and transforming healthcare practices.